- Report
- March 2025
- 1048 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- October 2024
- 182 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- April 2024
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- November 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- September 2024
- 500 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- March 2025
- 281 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- April 2024
- 496 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- December 2024
- 332 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- December 2024
- 598 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- March 2025
- 262 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- May 2024
- 224 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- September 2024
- 678 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- May 2024
- 343 Pages
Global
From €4562EUR$4,799USD£3,833GBP
- Report
- May 2024
- 204 Pages
Global
From €4562EUR$4,799USD£3,833GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more